Terumo Corp - ESG Rating & Company Profile powered by AI
This webpage of Terumo Corp was prepared by All Street Sevva using leading AI. If you are employed by Terumo Corp and you would like to licence your ESG rating, please contact us. This page includes a Q&A table for Terumo Corp.
Terumo Corp in the Medical Equipment, Supplies & Distribution industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Terumo Corp | 8.0 | High |
1 | Bioteque Corp | 8.0 | High |
1 | Amplitude Surgical SA | 8.0 | High |
... | ... | ... | |
380 | ZoomMed Inc | 0.0 | Low |
380 | iRay Technology Co Ltd | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Terumo Corp have an accelerator or VC vehicle to help deliver innovation?
Does Terumo Corp disclose current and historical energy intensity?
Does Terumo Corp report the average age of the workforce?
Does Terumo Corp reference operational or capital allocation in relation to climate change?
Does Terumo Corp disclose its ethnicity pay gap?
Does Terumo Corp disclose cybersecurity risks?
Does Terumo Corp offer flexible work?
Does Terumo Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Terumo Corp disclose the number of employees in R&D functions?
Does Terumo Corp conduct supply chain audits?
Does Terumo Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Terumo Corp conduct 360 degree staff reviews?
Does Terumo Corp disclose the individual responsible for D&I?
Does Terumo Corp disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Terumo Corp disclose current and / or historical scope 2 emissions?
Does Terumo Corp disclose water use targets?
Does Terumo Corp have careers partnerships with academic institutions?
Did Terumo Corp have a product recall in the last two years?
Does Terumo Corp disclose incidents of discrimination?
Does Terumo Corp allow for Work Councils/Collective Agreements to be formed?
Has Terumo Corp issued a profit warning in the past 24 months?
Does Terumo Corp disclose parental leave metrics?
Does Terumo Corp disclose climate scenario or pathway analysis?
Does Terumo Corp disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Terumo Corp disclose the pay ratio of women to men?
Does Terumo Corp support suppliers with sustainability related research and development?
Does Terumo Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Terumo Corp reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Terumo Corp involved in embryonic stem cell research?
Does Terumo Corp disclose GHG and Air Emissions intensity?
Does Terumo Corp disclose its waste policy?
Does Terumo Corp report according to TCFD requirements?
Does Terumo Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Terumo Corp disclose energy use targets?
Does Terumo Corp disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Terumo Corp have a policy relating to cyber security?
Have a different question?
Potential Risks for Terumo Corp
These potential risks are based on the size, segment and geographies of the company.
Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.